< Back to search
Filter
1

Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma

for
Cytokine Release Syndrome, Recurrent Multiple Myeloma,
Location: Columbus OH
Sponsor: Naresh Bumma

Sex: All

Age: 18+

Code: NCT07657312

Phase2, Recruiting

Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma

for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07456605

Phase1, Recruiting

Multivitamin and Mineral Supplementation and Healthy Aging

for
Healthy Aging, Multivitamin and Mineral Supplementation
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 40 - 60

Code: NCT07642869

Recruiting

Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies

for
Multiple System Atrophy (MSA), Healthy Adult, Parkinson Disease
Location: New Haven CT
Sponsor: MODAG GmbH

Sex: All

Age: 50 - 70+

Code: NCT07640555

Early_phase1, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Shirley NY, Farmington CT, Mineola NY, New York NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase3, Recruiting

Interested in new multiple sclerosis trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma

for
Multiple Myeloma
Location: Iowa City IA
Sponsor: Christopher Strouse

Sex: All

Age: 18+

Code: NCT07581704

Phase1, Recruiting

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

for
Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma,
Location: Fort Wayne IN
Sponsor: Grifols Biologicals, LLC

Sex: All

Age: 18+

Code: NCT07582432

Phase3, Recruiting

DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM

for
Multiple Myeloma, Refractory Multiple Myeloma,
Location: Boston MA
Sponsor: David Avigan

Sex: All

Age: 18+

Code: NCT07377435

Phase1, Recruiting

Halt Aging in Survivors of Blood Cancers

for
Hematological Malignancy, Leukemia, Lymphoid Leukemia,
Location: Omaha NE
Sponsor: University of Nebraska

Sex: All

Age: 50+

Code: NCT07292272

Recruiting

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

for
Multiple Myeloma
Location: Norwich CT, Bethesda MD, Fort Myers FL, Macon GA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07227311

Phase2, Recruiting

A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy

for
Non-hodgkin Lymphoma, Multiple Myeloma
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07249528

Recruiting

Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma

for
Relapsed Refractory Multiple Myeloma (RRMM)
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT07032714

Phase1, Recruiting

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Norfolk VA, Fairfax VA, Atlanta GA, Nashville TN,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07266441

Phase2, Recruiting

ELISA in Relapsed/Refractory MM

for
Relapsed Refractory Multiple Myeloma (RRMM),
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06832865

Phase2, Recruiting

HELP Study - Towards High Throughput and Efficient Long-axial PET With Oral [18F]FDG

for
Multiple Cancers, Multiple Indications Cancer,
Location: Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 19+

Code: NCT07295171

Recruiting

A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma

for
Multiple Myeloma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07454382

Phase2, Recruiting

Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma

for
Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07181941

Phase1, Phase2, Recruiting

Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma

for
Multiple Myeloma
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07200102

Phase1, Recruiting

Zimmer Biomet-RibFix Titan

for
Rib Fracture, Rib Fracture Multiple
Location: Indianapolis IN
Sponsor: Zimmer Biomet

Sex: All

Age: 18+

Code: NCT07485829

Recruiting

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant

for
Multiple Myeloma, Plasma Cell Leukemia
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT05405387

Phase2, Recruiting